1. HBW Insight
  2. >>Beauty
  3. >>Business
  4. >>Earnings

Rejuvenated A Year Into Saunders’ Return To Helm, B+L Refreshing Blink, Lumify Lines

 
• By Malcolm Spicer

Brimonidine tartrate eye drops remain key sales driver among Canadian firm’s consumer health lines with 12% growth in the latest quarter. B+L expects pending launch of preservative-free line extension to sustain Lumify as a driver as generics of original formulation are approved.

• Source: Shutterstock

Any honeymoon expected for Brent Saunders at Bausch + Lomb, Corporation may or may not be over after a year at the helm, but the special period known as market exclusivity the firm’s Lumify OTC switch eye drops enjoyed in the US could be passing with the first generic copy approved.

The brimonidine tartrate 0.025% ophthalmic solution indicated for relief of redness remains a key sales driver among the Canadian firm’s...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

E.l.f. Expects Sales To Double On International Growth, Rhode Acquisition

 
• By Eileen Francis

Oakland, Calif.-based e.l.f. Beauty, Inc. says it expects white space opportunities and the Hailey Bieber rhode lifestyle beauty acquisition to more than double its business in coming years.

NIVEA’s ‘Milestone’ Launch Brings ‘Breakthrough’ Anti-Aging Tech To Masses

 
• By Eileen Francis

Beiersdorf is launching NIVEA Epigenetics Rejuvenating Serum with Epicelline, the biggest launch in its history. The range will debut first in Europe, reaching 30 countries by the end of 2025.

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 
• By Malcolm Spicer

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.

Ulta ‘Beauty Unleashed’ Investment Delivers In Fiscal Q1

 
• By Eileen Francis

Retailer Ulta Beauty, Inc. reports net sales in the fiscal first quarter beat consensus estimates, rising 4.5% to $2.85bn, as the company sees benefits of its recently announced ‘Beauty Unleashed’ initiative.

More from Business

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 
• By Malcolm Spicer

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.

Interparfums Inks Fragrance License Deal With Parisian Fashion Brand Longchamp

 
• By Eileen Francis

New York-based Interparfums has signed a deal with Parisian firm Longchamp – known for its leather goods – for the creation and distribution of fragrance lines.

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By David Ridley

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.